Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$3.59 USD
-0.16 (-4.27%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $3.60 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.20 | -10.00% |
Earnings Summary
For their last quarter, Autolus Therapeutics (AUTL) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.19 per share. This reflects a negative earnings surprise of 15.79%. Look out for AUTL's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 23.08%.
Earnings History
Price & Consensus
Zacks News for AUTL
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
AUTL: What are Zacks experts saying now?
Zacks Private Portfolio Services